Alan MD - Mirati Ther Ex Officer
| MRTXDelisted Stock | USD 31.32 0.15 0.48% |
Insider
Alan MD is Ex Officer of Mirati Ther
| Age | 67 |
| Phone | 858 332 3410 |
| Web | https://www.mirati.com |
Mirati Ther Management Efficiency
The company has return on total asset (ROA) of (0.393) % which means that it has lost $0.393 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6995) %, meaning that it created substantial loss on money invested by shareholders. Mirati Ther's management efficiency ratios could be used to measure how well Mirati Ther manages its routine affairs as well as how well it operates its assets and liabilities.Mirati Ther currently holds 51.51 M in liabilities with Debt to Equity (D/E) ratio of 0.05, which may suggest the company is not taking enough advantage from borrowing. Mirati Ther has a current ratio of 9.9, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Mirati Ther's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Louise RodinoKlapac | Sarepta Therapeutics | 46 | |
| Gina Mazzariello | Amylyx Pharmaceuticals | 53 | |
| Katherine Tuminello | Krystal Biotech | N/A | |
| MS MBA | Krystal Biotech | 59 | |
| Margaret MBA | Amylyx Pharmaceuticals | 59 | |
| Joshua Cohen | Amylyx Pharmaceuticals | 32 | |
| Mike Preigh | Day One Biopharmaceuticals | N/A | |
| MBA JD | Apellis Pharmaceuticals | 51 | |
| Sharen Pyatetskaya | Hepion Pharmaceuticals | ||
| Julie MBA | Day One Biopharmaceuticals | 42 | |
| William Ciambrone | Sarepta Therapeutics | 60 | |
| Mark Vignola | Terns Pharmaceuticals | 46 | |
| Jaa Roberson | Day One Biopharmaceuticals | N/A | |
| Alex Kane | PTC Therapeutics | N/A | |
| Paul MD | Madrigal Pharmaceuticals | 81 | |
| Stephen MD | Hepion Pharmaceuticals | N/A | |
| Rebecca MD | Madrigal Pharmaceuticals | 72 | |
| Chris Aiello | Amylyx Pharmaceuticals | N/A | |
| David Glynn | Krystal Biotech | N/A | |
| James MBA | Amylyx Pharmaceuticals | 57 | |
| Charles II | Day One Biopharmaceuticals | 47 | |
Management Performance
| Return On Equity | -0.7 | |||
| Return On Asset | -0.39 |
Mirati Ther Leadership Team
Elected by the shareholders, the Mirati Ther's board of directors comprises two types of representatives: Mirati Ther inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Mirati. The board's role is to monitor Mirati Ther's management team and ensure that shareholders' interests are well served. Mirati Ther's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Mirati Ther's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Benjamin MBA, Chief Officer | ||
| Michael Paolucci, Chief Officer | ||
| Alan MD, Ex Officer | ||
| James Christensen, Chief Scientific Officer and Sr. VP | ||
| Kelly Covello, VP Affairs | ||
| Ryan Asay, VP Affairs | ||
| Laurie Stelzer, Chief Officer | ||
| Reena Desai, Chief Sec | ||
| David Meek, CEO Director |
Mirati Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Mirati Ther a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.7 | |||
| Return On Asset | -0.39 | |||
| Operating Margin | (10.49) % | |||
| Current Valuation | 3.19 B | |||
| Shares Outstanding | 70.15 M | |||
| Shares Owned By Insiders | 1.72 % | |||
| Shares Owned By Institutions | 98.28 % | |||
| Number Of Shares Shorted | 4.39 M | |||
| Price To Earning | (3.97) X | |||
| Price To Book | 4.35 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in Mirati Stock
If you are still planning to invest in Mirati Ther check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mirati Ther's history and understand the potential risks before investing.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |